| 1 |
Yanagisawa Y. How dietary amino acids and high protein diets influence insulin secretion. Physiol Rep 2023;11:e15577. [PMID: 36695783 DOI: 10.14814/phy2.15577] [Reference Citation Analysis]
|
| 2 |
Rehfeld JF. Four sidenotes about glucagon peptides. Peptides 2023;159:170924. [PMID: 36521797 DOI: 10.1016/j.peptides.2022.170924] [Reference Citation Analysis]
|
| 3 |
Mikkelsen RB, Arora T, Trošt K, Dmytriyeva O, Jensen SK, Meijnikman AS, Olofsson LE, Lappa D, Aydin Ö, Nielsen J, Gerdes V, Moritz T, van de Laar A, de Brauw M, Nieuwdorp M, Hjorth SA, Schwartz TW, Bäckhed F. Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration. iScience 2022;25:105683. [PMID: 36561890 DOI: 10.1016/j.isci.2022.105683] [Reference Citation Analysis]
|
| 4 |
Lok KH, Wareham NJ, Nair RS, How CW, Chuah LH. Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment. Pharmacol Res 2022;180:106237. [PMID: 35487405 DOI: 10.1016/j.phrs.2022.106237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Hjørne AP, Modvig IM, Holst JJ. The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion. Metabolites 2022;12:420. [DOI: 10.3390/metabo12050420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 6 |
Zhang F, Li DX, Lu DY, Lu YF, Zhang R, Zhao LL, Ji S, Guo MZ, Du Y, Tang DQ. Analysis of plasma free amino acids in diabetic rat and the intervention of Ginkgo biloba leaves extract using hydrophilic interaction liquid chromatography coupled with tandem mass-spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1196:123230. [PMID: 35349934 DOI: 10.1016/j.jchromb.2022.123230] [Reference Citation Analysis]
|
| 7 |
Bhutia YD, Mathew M, Sivaprakasam S, Ramachandran S, Ganapathy V. Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6). Biomolecules 2022;12:235. [DOI: 10.3390/biom12020235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Roberts A, Phuah P, Cheng S, Murphy KG. Targeting Enteroendocrine Cells to Treat Metabolic Disease. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00068-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]
|
| 10 |
Macías-Acosta MP, Valerdi-Contreras L, Bustos-Angel ED, García-Reyes RA, Alvarez-Zavala M, González-Ávila M. Involvement of the fecal amino acid profile in a clinical and anthropometric study of Mexican patients with insulin resistance and type 2 diabetes mellitus. Amino Acids 2021. [PMID: 34821993 DOI: 10.1007/s00726-021-03107-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Rehfeld JF. Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions. Molecules 2021;26:5657. [PMID: 34577128 DOI: 10.3390/molecules26185657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Watkins JD, Koumanov F, Gonzalez JT. Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review. Adv Nutr 2021;12:2540-52. [PMID: 34192748 DOI: 10.1093/advances/nmab078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Smitka K, Prochazkova P, Roubalova R, Dvorak J, Papezova H, Hill M, Pokorny J, Kittnar O, Bilej M, Tlaskalova-Hogenova H. Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders. Front Endocrinol (Lausanne) 2021;12:613983. [PMID: 33953692 DOI: 10.3389/fendo.2021.613983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Schalla MA, Taché Y, Stengel A. Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake. Compr Physiol 2021;11:1679-730. [PMID: 33792904 DOI: 10.1002/cphy.c200007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Barella LF, Jain S, Kimura T, Pydi SP. Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J 2021;288:2622-44. [PMID: 33682344 DOI: 10.1111/febs.15800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 16 |
Campbell SA, Johnson J, Light PE. Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1. Islets 2021;13:32-50. [PMID: 33724156 DOI: 10.1080/19382014.2021.1889941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Lu VB, Gribble FM, Reimann F. Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion. Nutrients 2021;13:883. [PMID: 33803183 DOI: 10.3390/nu13030883] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 18 |
Grunddal KV, Diep TA, Petersen N, Tough IR, Skov LJ, Liu L, Buijink JA, Mende F, Jin C, Jepsen SL, Sørensen LME, Achiam MP, Strandby RB, Bach A, Hartmann B, Frimurer TM, Hjorth SA, Bouvier M, Cox H, Holst B. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist. Mol Metab 2021;49:101207. [PMID: 33711555 DOI: 10.1016/j.molmet.2021.101207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Kurtz R, Anderman MF, Shepard BD. GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2021;320:G304-18. [PMID: 33205999 DOI: 10.1152/ajpgi.00275.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Modvig IM, Kuhre RE, Jepsen SL, Xu SFS, Engelstoft MS, Egerod KL, Schwartz TW, Ørskov C, Rosenkilde MM, Holst JJ. Amino acids differ in their capacity to stimulate GLP-1 release from the perfused rat small intestine and stimulate secretion by different sensing mechanisms. Am J Physiol Endocrinol Metab 2021;320:E874-85. [PMID: 33645250 DOI: 10.1152/ajpendo.00026.2021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 21 |
Delobel M, Dalle S. G-protein–coupled receptors controlling pancreatic β-cell functional mass for the treatment of type 2 diabetes. Current Opinion in Endocrine and Metabolic Research 2021;16:113-118. [DOI: 10.1016/j.coemr.2020.09.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Hu X, Guo F. Amino Acid Sensing in Metabolic Homeostasis and Health. Endocr Rev 2021;42:56-76. [PMID: 33053153 DOI: 10.1210/endrev/bnaa026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 23 |
Yang M, Reimann F, Gribble FM. Chemosensing in enteroendocrine cells: mechanisms and therapeutic opportunities. Curr Opin Endocrinol Diabetes Obes 2021;28:222-31. [PMID: 33449572 DOI: 10.1097/MED.0000000000000614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Hajishafiee M, Elovaris RA, Jones KL, Heilbronn LK, Horowitz M, Poppitt SD, Feinle-Bisset C. Effects of intragastric administration of L-tryptophan on the glycaemic response to a nutrient drink in men with type 2 diabetes - impacts on gastric emptying, glucoregulatory hormones and glucose absorption. Nutr Diabetes 2021;11:3. [PMID: 33414406 DOI: 10.1038/s41387-020-00146-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Schöneberg T, Liebscher I. Mutations in G Protein-Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches. Pharmacol Rev 2021;73:89-119. [PMID: 33219147 DOI: 10.1124/pharmrev.120.000011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 26 |
Cosín-Roger J, Ortiz-Masia D, Barrachina MD, Calatayud S. Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment? Cells 2020;9:E2345. [PMID: 33113952 DOI: 10.3390/cells9112345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Yao Y, Chen H, Yan L, Wang W, Wang D. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Biomed Pharmacother 2020;131:110669. [PMID: 32937246 DOI: 10.1016/j.biopha.2020.110669] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 28 |
Gimeno RE, Briere DA, Seeley RJ. Leveraging the Gut to Treat Metabolic Disease. Cell Metab 2020;31:679-98. [PMID: 32187525 DOI: 10.1016/j.cmet.2020.02.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 29 |
Liu LZ, Ma T, Zhou J, Long Hu Z, Jun Zhang X, Zhen Zhang H, Zeng M, Liu J, Li L, Jiang Y, Zou Z, Wang F, Zhang L, Xu J, Wang J, Xiao F, Fang X, Zou H, Efanov AM, Thomas MK, Lin HV, Chen J. Discovery of LY3325656: A GPR142 agonist suitable for clinical testing in human. Bioorg Med Chem Lett 2020;30:126857. [PMID: 31982234 DOI: 10.1016/j.bmcl.2019.126857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 30 |
Reimann F, Diakogiannaki E, Hodge D, Gribble FM. Cellular mechanisms governing glucose-dependent insulinotropic polypeptide secretion. Peptides 2020;125:170206. [PMID: 31756367 DOI: 10.1016/j.peptides.2019.170206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 31 |
Martin AM, Sun EW, Keating DJ. Mechanisms controlling hormone secretion in human gut and its relevance to metabolism. J Endocrinol 2019;244:R1-R15. [PMID: 31751295 DOI: 10.1530/JOE-19-0399] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 32 |
Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Glucagon-like peptide 1 (GLP-1). Mol Metab 2019;30:72-130. [PMID: 31767182 DOI: 10.1016/j.molmet.2019.09.010] [Cited by in Crossref: 451] [Cited by in F6Publishing: 492] [Article Influence: 112.8] [Reference Citation Analysis]
|
| 33 |
Karras SN, Koufakis T, Mustafa OG, Kotsa K. Anti-incretin effect: The other face of Janus in human glucose homeostasis. Obes Rev 2019;20:1597-607. [PMID: 31347774 DOI: 10.1111/obr.12917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Vedel L, Nøhr AC, Gloriam DE, Bräuner-Osborne H. Pharmacology and function of the orphan GPR139 G protein-coupled receptor. Basic Clin Pharmacol Toxicol 2020;126 Suppl 6:35-46. [PMID: 31132229 DOI: 10.1111/bcpt.13263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
